Number of qualified clients: CDEC talked over the uncertainty in the amount of patients with moderately serious to extreme hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some clients who will be categorised as getting mild or average disease could have a critical https://jaidenwxzic.p2blogs.com/34552102/the-best-side-of-hemgenix